Operating Lease, Liability of LeonaBio, Inc. from 30 Sep 2020 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease.
- Summary
-
LeonaBio, Inc. quarterly Operating Lease, Liability in USD history and change rate from 30 Sep 2020 to 31 Dec 2025.
- LeonaBio, Inc. Operating Lease, Liability for the quarter ending 31 Dec 2025 was $803,000, a 34% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)
LeonaBio, Inc. Quarterly Operating Lease, Liability (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $803,000 | -$414,000 | -34% | 31 Dec 2025 | 10-K | 31 Mar 2026 | 2025 | FY |
| Q3 2025 | $912,000 | -$402,000 | -31% | 30 Sep 2025 | 10-Q | 06 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $1,017,000 | -$390,000 | -28% | 30 Jun 2025 | 10-Q | 07 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $1,118,000 | -$380,000 | -25% | 31 Mar 2025 | 10-Q | 09 May 2025 | 2025 | Q1 |
| Q4 2024 | $1,217,000 | -$368,000 | -23% | 31 Dec 2024 | 10-K | 27 Feb 2025 | 2024 | FY |
| Q3 2024 | $1,314,000 | -$358,000 | -21% | 30 Sep 2024 | 10-Q | 07 Nov 2024 | 2024 | Q3 |
| Q2 2024 | $1,407,000 | -$347,000 | -20% | 30 Jun 2024 | 10-Q | 01 Aug 2024 | 2024 | Q2 |
| Q1 2024 | $1,498,000 | -$336,000 | -18% | 31 Mar 2024 | 10-Q | 15 May 2024 | 2024 | Q1 |
| Q4 2023 | $1,585,000 | -$326,000 | -17% | 31 Dec 2023 | 10-K | 22 Feb 2024 | 2023 | FY |
| Q3 2023 | $1,672,000 | -$316,000 | -16% | 30 Sep 2023 | 10-Q | 09 Nov 2023 | 2023 | Q3 |
| Q2 2023 | $1,754,000 | -$307,000 | -15% | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $1,834,000 | -$17,000 | -0.92% | 31 Mar 2023 | 10-Q | 11 May 2023 | 2023 | Q1 |
| Q4 2022 | $1,911,000 | -$9,000 | -0.47% | 31 Dec 2022 | 10-K | 23 Mar 2023 | 2022 | FY |
| Q3 2022 | $1,988,000 | +$1,000 | +0.05% | 30 Sep 2022 | 10-Q | 10 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $2,061,000 | +$17,000 | +0.83% | 30 Jun 2022 | 10-Q | 15 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $1,851,000 | -$49,000 | -2.6% | 31 Mar 2022 | 10-Q | 12 May 2022 | 2022 | Q1 |
| Q4 2021 | $1,920,000 | +$920,000 | +92% | 31 Dec 2021 | 10-K | 28 Mar 2022 | 2021 | FY |
| Q3 2021 | $1,987,000 | +$1,015,000 | +104% | 30 Sep 2021 | 10-Q | 10 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $2,044,000 | 30 Jun 2021 | 10-Q | 16 Aug 2021 | 2021 | Q2 | ||
| Q1 2021 | $1,900,000 | 31 Mar 2021 | 10-Q | 13 May 2021 | 2021 | Q1 | ||
| Q4 2020 | $1,000,000 | 31 Dec 2020 | 10-K | 25 Mar 2021 | 2020 | FY | ||
| Q3 2020 | $972,000 | 30 Sep 2020 | 10-Q | 12 Nov 2020 | 2020 | Q3 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.